Cybrdi Inc (CYDI) financial statements (2020 and earlier)

Company profile

Business Address 401 ROSEMONT AVENUE
FREDERICK, MD 21701
State of Incorp. CA
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments204956
Cash and cash equivalents204956
Receivables60
Inventory, net of allowances, customer advances and progress billings849816
Inventory849816
Advances on inventory purchases53
Prepaid expense and other current assets93
Other undisclosed current assets906 
Total current assets:1,9701,869
Noncurrent Assets
Property, plant and equipment1,1451,190
Intangible assets, net (including goodwill)628661
Intangible assets, net (excluding goodwill)628661
Other undisclosed noncurrent assets6,6106,832
Total noncurrent assets:8,3838,683
TOTAL ASSETS:10,35310,552
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities822690
Accounts payable124
Accrued liabilities810686
Debt1,3091,664
Due to related parties2,9632,071
Deferred revenue and credits126122
Deferred tax liabilities1110
Other liabilities592571
Other undisclosed current liabilities165149
Total current liabilities:5,9885,279
Noncurrent Liabilities
Other undisclosed noncurrent liabilities376846
Total noncurrent liabilities:376846
Total liabilities:6,3646,125
Stockholders' equity
Stockholders' equity attributable to parent, including:2,9543,375
Common stock4,3144,314
Additional paid in capital172172
Accumulated other comprehensive income1,6571,530
Accumulated deficit(3,526)(2,977)
Other undisclosed stockholders' equity attributable to parent337337
Stockholders' equity attributable to noncontrolling interest1,0351,052
Total stockholders' equity:3,9884,427
TOTAL LIABILITIES AND EQUITY:10,35310,552

Income statement (P&L) ($ in thousands)

12/31/2013
12/31/2012
Revenues574783
Revenue, net 269
Cost of revenue(390)(616)
Cost of goods and services sold (221)
Gross profit:184167
Operating expenses(726)(599)
Operating loss:(542)(432)
Nonoperating expense(72)(223)
Investment income, nonoperating(221)(195)
Other nonoperating income (expense)149(28)
Loss from continuing operations before income taxes:(615)(655)
Income tax expense(2)(1)
Net loss:(617)(656)
Net income attributable to noncontrolling interest68126
Net loss available to common stockholders, diluted:(548)(530)

Comprehensive Income ($ in thousands)

12/31/2013
12/31/2012
Net loss:(617)(656)
Comprehensive loss:(617)(656)
Comprehensive loss, net of tax, attributable to noncontrolling interest(68)(126)
Other undisclosed comprehensive income, net of tax, attributable to parent264241
Comprehensive loss, net of tax, attributable to parent:(422)(540)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: